Koa Health appoints Dr Anna Mandeville as UK Clinical Director and Leslie Norwalk to the Supervisory Board
pharmafile | March 1, 2023 | Appointment | Business Services |
London, 1st March 2023: Koa Health, a leading global provider of digital mental healthcare solutions, today announces that Dr Anna Mandeville has joined the company’s team as UK Clinical Director, and Leslie Norwalk has been appointed to the company’s Supervisory Board. Anna will oversee the development of Koa Health’s clinical services, and Leslie will serve as an advisor on the US healthcare system.
Dr Oliver Harrison, CEO, Koa Health said, “Around the world, people are grappling with the mental health impact of the cost-of-living crisis and political and economic instability (following three years of pandemic). At Koa, we recognize that mental health is a continuum, so we provide a range of services, from prevention to treating early symptoms to clinical treatment to support people across their mental health journey. We are delighted to welcome Anna’s clinical experience and Leslie’s deep understanding of the US healthcare system. Anna and Leslie will be instrumental in helping us to deliver our vision of mental health for everyone”.
Dr Anna Mandeville brings a wealth of experience in Clinical Psychology to the Koa Health Team. She most recently served as Divisional Lead for Psychological Services in Enfield at BEH Mental Health Trust in the U.K., where she led the service design and quality monitoring of a range of physical and mental health services. As part of her tenure at University College London Hospitals NHS Foundation Trust, Anna worked leading and transforming psychological services across the London region and developed national psychological services in chronic pain management. She was selected as an outstanding NHS leader to receive a fully-funded fellowship from the Health Foundation and graduated from Ashridge Business School in 2019 with a Master’s in Leadership and Quality improvement. Anna is an honorary lecturer at UCL.
Leslie Norwalk’s extensive leadership experience in the U.S. Government healthcare industry brings an invaluable perspective to Koa Health. She serves as Strategic Counsel for Epstein Becker & Green P.C. Previously, Leslie served as Acting Administrator for the Centers for Medicare & Medicaid Services. Throughout her accomplished career, she has served on boards across a wide spectrum of healthcare corporations and biotechnology companies, including NuVasive, ModivCare, Neurocrine Biosciences, and Arvinas. Leslie is also a member of APCO Worldwide’s International Advisory Council.
Anna Mandeville, UK Clinical Director, Koa Health, said, “The WHO estimates that one in eight people globally suffer from a mental health disorder, and that number doesn’t include the many who struggle from mental health issues from time to time and would benefit from proactive and preventative care. Increasing access to evidence-based digital mental health tools is the best way to support the demand for mental health services across the full continuum of mental health. I’m looking forward to supporting Koa Health, developing and delivering high-quality clinical services, and working with the expert team”.
Leslie Norwalk, Strategic Advisor, Koa Health, said, “In such a critical time of change for the healthcare industry, I am looking forward to working with Koa Health to further its mission to provide effective, clinically validated, and accessible digital mental health solutions that cover the full spectrum from prevention to treatment”.